Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia

Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia: A Pilot Feasibility Study

This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. The Google Translate "Conversation Mode" translation application is designed to provide translation from one language to another and used to allow the nurse or study doctor to communicate with patients in Spanish by asking pre-prepared questions through an electronic device such as an iPad or iPhone. Google Translate "Conversation Mode" may facilitate assessment of pain and nausea after surgery in Spanish speaking patients.

Study Overview

• Status: Completed
• Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
• Intervention / Treatment: Other: Survey Administration; Other: Medical Device Usage and Evaluation

Detailed Description

PRIMARY OBJECTIVE:

I. To determine the feasibility of Google Translate "Conversation Mode" use to assess postoperative surgical pain presence, location and intensity, and nausea presence and intensity in Spanish speaking patients in the post-anesthesia care unit (PACU).

SECONDARY OBJECTIVES:

I. To evaluate the length of stay in PACU. II. To assess patient satisfaction with regards to pain/nausea experienced in PACU.

III. To determine nursing satisfaction with regards to the use of Google Translate "Conversation Mode".

OUTLINE:

Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.

• Study Type: Observational
• Enrollment (Actual): 30

Contacts and Locations

Study Locations

• United States
  • Texas
    • Houston, Texas, United States, 77030
      • M D Anderson Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients with scheduled surgery under general anesthesia and will require translation services as part of standard care

Description

Inclusion Criteria:

• Ability to provide written informed consent
• Patients between 18-80 years of age whose primary language is Spanish and will require translation services as part of standard care
• American Society of Anesthesiologists physical status (ASA) 1-3
• Are scheduled surgery under general anesthesia
• Ability to understand and complete all study questionnaires

Exclusion Criteria:

• Emergency surgery
• ASA >= 4
• Patients who do not require official translation services for consent purposes
• Patients who have chronic pain and/or are taking opioids chronically (daily intake for more than a month before surgery)
• Patients who undergo craniotomy
• Patients with a hearing impairment that prevents the ability to hear the recorded statements; and/or a cognitive impairment that would prevent them from completing post-op assessments

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Health services research (Google Translate Conversation Mode); Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.	Other: Survey Administration; Complete survey; Other: Medical Device Usage and Evaluation; Use Google Translate "Conversation Mode" translation application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Ability to respond to the questions when asked using Google Translate	The feasibility rate and its 95% confidence interval will be estimated.	1 year

Collaborators and Investigators

• Sponsor: M.D. Anderson Cancer Center

Publications and helpful links

Helpful Links

• MD Anderson Cancer Center Website

Study record dates

Study Major Dates

• Study Start (Actual): June 22, 2021
• Primary Completion (Actual): March 22, 2022
• Study Completion (Actual): March 22, 2022

Study Registration Dates

• First Submitted: September 15, 2021
• First Submitted That Met QC Criteria: September 24, 2021
• First Posted (Actual): September 29, 2021

Study Record Updates

• Last Update Posted (Actual): April 4, 2022
• Last Update Submitted That Met QC Criteria: March 22, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: 2020-1345 (Other Identifier: M D Anderson Cancer Center); NCI-2021-09116 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No